Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Telix Doses First Patient in SOLACE Trial for Metastatic Bone Pain 2025-10-23 04:00
SynbioTech Brings Taiwan's Biotech Excellence to the Global Stage with TWK10® for Muscle Performance and Healthy Aging 2025-10-23 00:00
Largest Milestone Payment Secured: Biokin, a Rising Chinese Pharmaceutical MNC 2025-10-22 23:39
Blood Publishes Promising Results of IASO Bio's Anti-GPRC5D CAR-T RD118 in Relapsed/Refractory Multiple Myeloma 2025-10-22 19:39
Cambrex Unveils $120 Million Investment to Expand API Manufacturing and Strengthen U.S. Drug Supply Resilience 2025-10-22 18:00
LISCure BioSciences Secures World's First Approval for "Joint Health Probiotic" as Recognized Health Functional Ingredient 2025-10-22 14:28
Renalys Pharma Announces Support for Alport Syndrome Registry Study Organized by Japanese Society for Pediatric Nephrology 2025-10-22 14:00
ACM Biolabs Reports Favorable Safety Signals and Early Pharmacodynamics from Intramuscular Administration of ACM-CpG in Patients with Advanced Solid Tumors 2025-10-22 14:00
ACROBiosystems and Partners Conclude OrganoAsia 2025 2025-10-22 11:03
ACROBiosystems and Partners Conclude OrganoAsia 2025 2025-10-22 11:01
WuXi Biologics Included in Hang Seng Corporate Sustainability Benchmark Index 2025-10-22 08:30
HanchorBio Secures US Patent for Innovative SIRPα/CD47 Fusion Protein HCB101 2025-10-21 19:00
Abbott and BIG CARiNG Group Launch Nationwide Influenza Awareness Program to Strengthen Public Health Response Through Early Intervention 2025-10-21 13:12
SK Biopharmaceuticals Launches Joint Venture with Eurofarma for AI-based Epilepsy Management Platform 2025-10-21 09:20
Exploring the Next Era of Cell & Gene Therapy with Nobel Laureate in London 2025-10-20 19:43
HanchorBio Showcases Pipeline Momentum with HCB101 and HCB301 Data Across Five Major Oncology Meetings in Q4 2025 2025-10-20 19:00
The New England Journal of Medicine Publishes Results of Phase III OptiTROP-Lung04 Study of Sacituzumab Tirumotecan in Advanced EGFR-TKI-Resistant NSCLC 2025-10-20 17:06
Live from ESMO | Hengrui Debuts Exhibition Booth with Landmark Data Showcasing Pharma's Emerging Innovation Power 2025-10-20 14:20
Kelun-Biotech Presents Positive Phase 3 Data for Trastuzumab Botidotin Compared to T-DM1 at 2025 ESMO 2025-10-20 13:59
Biparatopic HER2-targeting ADC JSKN003 Was Granted Another Breakthrough Therapy Designation for HER2-Positive Advanced Colorectal Cancer 2025-10-20 13:21
1 10 11 12 13 14 481